Cancer's Achilles' Heel: Apoptosis and Necroptosis to the Rescue
Atreyi Dasgupta1, Motonari Nomura2, Ryan Shuck3
1Department of Pediatrics, Texas Children's Cancer and Hematology Centers, Baylor College of Medicine, Houston, TX 77030, USA. adasgupt@bcm.edu.
Abstract:
Apoptosis, and the more recently discovered necroptosis, are two avenues of programmed cell death. Cancer cells survive by evading these two programs, driven by oncogenes and tumor suppressor genes. While traditional therapy using small molecular inhibitors and chemotherapy are continuously being utilized, a new and exciting approach is actively underway by identifying and using synergistic relationship between driver and rescue genes in a cancer cell. Through these synthetic lethal relationships, we are gaining tremendous insights into tumor vulnerabilities and specific molecular avenues for induction of programmed cell death. In this review, we briefly discuss the two cell death processes and cite examples of such synergistic manipulations for therapeutic purposes.
Insights
Cancer cells evade programmed cell death pathways like apoptosis and necroptosis. Researchers are exploring synthetic lethal relationships between genes to target these vulnerabilities and induce cell death for cancer therapy.
Area of Science:
- Molecular Biology
- Oncology
- Cell Death Research
Background:
- Cancer cells possess mechanisms to evade programmed cell death, including apoptosis and necroptosis.
- Oncogenes and tumor suppressor genes play a critical role in cancer cell survival by interfering with these cell death pathways.
Purpose of the Study:
- To review programmed cell death processes (apoptosis and necroptosis).
- To explore novel therapeutic strategies targeting cancer cell vulnerabilities through synthetic lethal relationships.
- To highlight the potential of exploiting gene interactions for cancer treatment.
Main Methods:
- Literature review of programmed cell death mechanisms.
- Analysis of oncogene and tumor suppressor gene functions in cancer survival.
- Identification and discussion of synergistic gene manipulations for therapeutic purposes.
Main Results:
- Cancer cells actively evade apoptosis and necroptosis.
- Synthetic lethal interactions between driver and rescue genes reveal tumor-specific vulnerabilities.
- These interactions offer new molecular avenues for inducing programmed cell death.
Conclusions:
- Understanding programmed cell death pathways is crucial for cancer therapy.
- Exploiting synthetic lethality presents a promising strategy for targeted cancer treatment.
- Further research into gene synergy can lead to innovative therapeutic approaches.
Related Concept Videos
01:30Apoptosis
01:30Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
01:16Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
01:18Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
01:31The Intrinsic Apoptotic Pathway
01:17The Extrinsic Apoptotic Pathway